The diagnosis of multiple sclerosis (MS) is usually straightforward in patients who present with a typical clinical history. When symptoms that are not specific to MS or are atypical of MS occur, however, ancillary tests have a more dominant role. MRI is the most com monly performed investigation that can support a clini cal diagnosis of MS 1,2 and, for a considerable proportion of patients, can even replace some clinical criteria by revealing brain and spinal cord changes that are typical of MS. MRI can also be useful for ruling out alternative neurological diseases 3 . The diagnostic criteria for MS focus on white mat ter lesion (WML) abundance and dissemination in space and time 4 , but these criteria alone cannot con firm a diagnosis of MS or rule out other diagnoses because WMLs occur in many diseases and clinical conditions. Therefore, characteristics such as lesions at different ages (acute and chronic), Dawson fingers, juxta cortical lesions and short partial and eccentric spinal cord lesions can support a diagnosis of MS 2, 5, 6 (FIG. 1) .
. The diagnostic criteria for MS focus on white mat ter lesion (WML) abundance and dissemination in space and time 4 , but these criteria alone cannot con firm a diagnosis of MS or rule out other diagnoses because WMLs occur in many diseases and clinical conditions. Therefore, characteristics such as lesions at different ages (acute and chronic), Dawson fingers, juxta cortical lesions and short partial and eccentric spinal cord lesions can support a diagnosis of MS 2, 5, 6 (FIG. 1) .
However, diagnostic imaging criteria 1, 2, 4, 7 were created to predict the development of MS in patients with a clinically isolated syndrome (CIS) that suggests inflam matory demyelination, a clinical presentation typical of MS. If used outside of this context in an attempt to dis tinguish MS from other disorders, such criteria might not perform well because they are fulfilled by a consid erable proportion of patients with other neurological diseases [8] [9] [10] [11] [12] [13] [14] [15] [16] (TABLE 1) . Therefore, their use in this way could lead to unnecessary anxiety, misdiagnosis and inappropriate treatment 17 . Red flags that were described over a decade ago by the European Magnetic Resonance Network in MS (MAGNIMS) 18 have guided clinicians who are consid ering a diagnosis of MS, but several new developments in the MS imaging field have occurred in the past decade. First, the coexistence of agerelated changes and vascular disease has been recognized in patients with MS, and these comorbidities pose particular diagnostic chal lenges. Second, features have been described that distin guish MS from the newly recognized antibody mediated syndromes of neuromyelitis optica spectrum dis orders (NMOSDs) and acute demyelinating encephalo myelitis (ADEM), both of which are associated with antiaquaporin 4 (AQP4) antibodies and antimyelin oligodendrocyte glycoprotein (MOG) antibodies. Last, advances in the latest MRI techniques have identified promising diseasespecific features. 18 and Jacqueline Palace 1 Taking these developments into account, a MAGNIMS workshop was held for three purposes. The first pur pose was to update the imaging features that differ entiate between MS and its most common imaging mimics, particularly agerelated cerebrovascular disease and NMOSD (including antiMOG antibody associated disease), on 1.5-3T conventional MRI using clinical diagnostic sequences (for example, T2weighted MRI and T2weighted fluidattenuated inversion recovery (FLAIR), and precontrast and postcontrast T1weighted scans) 19, 20 . Data from 7T MRI were not considered in this Review owing to the limited clinical relevance at present. The second purpose of the workshop was to determine the utility of other MRI techniques, such as susceptibility weighted imaging (SWI) double inversion recovery (DIR), proton magnetic resonance spectroscopy (MRS), magnetization transfer ratio (MTR) and diffusion tensor imaging (DTI), which appear promising for identifying diseasespecific features 21 . Finally, we also examined advances that have been made in identifying imaging hallmarks that can differentiate relatively uncommon MS mimics from MS. In this Review, we present the findings of this workshop in relation to the use of MRI to distin guish MS from other white matter disorders and propose a practical diagnostic algorithm (FIG. 2) .
Cerebrovascular disease and ageing
Imaging similarities to MS Most neurologists and neuroradiologists would be unsure of the diagnosis for a 50yearold patient who is a current smoker and presents with progressive walking difficulties and WMLs on brain MRI. This difficulty is because the most common causes of WMLs are age related changes and/or vascular disease, but MS lesions can look similar [22] [23] [24] . WMLs can indicate diverse under lying processes related to a broad spectrum of vascular disorders, among which cerebral small vessel disease (SVD) is particularly important. SVD is pathologi cally heterogeneous and best considered as a group of diseases 25 rather than as a single entity (TABLE 2) . Small vessels, such as veins and arterioles with a diameter <500 μm, cannot be studied easily in vivo, and signs of parenchymal damage, such as WMLs, lacunae, widened Virchow-Robin spaces and microbleeds, are used as MRI surrogate markers for SVD 26 (FIG. 3) . These vascular features become more numerous with age and influence functional outcomes and mortality 27, 28 . Agerelated white matter changes are hetero geneous 29 . Periventricular pencilthin lining of the ventricles is commonly seen in normal ageing (frequently already detect able in the 5th to 6th decades of life), followed by socalled caps (hyperintense lining of the frontal and occipital horns of the lateral ventricle; FIG. 3) and bands (thicker hyperintense lining parallel and adjacent to the walls of the lateral ventricles), which can indicate ependy mal loss, subependymal gliosis and widened extracellular spaces. Irregular and discontinuous periventricular bands are also common in ageing but are also associated with other features of SVD and with periventricular venous collagenosis 30 . Punctate periventricular WMLs are fre quently seen in ageing, even in people aged <50 years, can be of vascular or nonvascular origin and are relatively stable over time 29 . Early confluent WMLs and confluent periventricular WMLs are less common than the previ ously mentioned features but can progress faster, thereby mimicking the evolution of MS lesions, and are more strongly associated with vascular risk factors 31 , lacunae 32 and clinical disability 33 . These agerelated and ischae mic periventricular white matter changes have not been studied separately in MS but are difficult to distinguish from periventricular MS lesions.
• MRI is crucial in the diagnosis of multiple sclerosis (MS), revealing the dissemination in space and time of white matter lesions (WMLs) and helping to rule out alternative diagnoses • WMLs with a distribution similar to that seen in MS can occur in many disorders, from common age-related vascular disease and migraine to neuromyelitis optica spectrum disorders and rarer conditions • The distribution of WMLs can help to differentiate MS from antibody-mediated CNS disorders • The proportion of lesions that exhibit the central vein sign and the presence of cortical lesions can be useful in differentiating MS from some of its mimics • Meningeal enhancement, indistinct (ill-defined) lesions that increase in size over time, macrobleeds and microbleeds, infarcts, cavities, symmetrical lesions that spare U-fibres, siderosis and extensive spinal cord lesions suggest diagnoses other than MS • We suggest the mnemonic iMIMICs to remember the atypical MRI features that indicate a diagnosis other than MS
U-fibres
Short association fibres that connect adjacent gyri of the brain, located within the cortex or immediately beneath it in the outermost parts of the subcortical white matter.
Widened Virchow-Robin spaces are often seen around the anterior commissure in early adulthood and near the vertex in older people (usually aged >50 years). In cerebral amyloid angiopathy, this feature can also be present at the centrum semiovale 34 . In MS, however, widened Virchow-Robin spaces are more prevalent, particularly in highconvexity brain areas 35 , which might indicate a perivascular inflammatory component of the disease or be an indirect marker of cerebral atrophy 36 . Brain volume loss occurs at a higher rate (0.5-1% per year) in MS than in healthy ageing (0.1-0.3% per year) 37 , although interpretation of volume loss at the individual level is difficult.
Patients with MS develop agerelated changes and vascular comorbidities over time, and these factors can affect clinical outcomes. Indeed, disability in MS is strongly associated with age 38 and vascular risk factors 39, 40 . Vascular risk factors are also associated with worse imaging outcomes in MS: smoking is associated with decreased wholebrain volume, obesity is associated with increased T1hypointense lesion volume, and arte rial hypertension and heart disease are associated with decreased grey matter and cortical volumes 41 . Therefore, the presence of vascular risk factors should be considered when interpreting imaging results in patients with MS.
Differentiation from MS
Brain lesion distribution and lesion features. The loca tion and shape of lesions (FIG. 1 Cerebral microbleeds detected with SWI (T2* weighted) 43 reflect haemosiderin deposits in the vessel walls and are a marker of vasculopathy that is most commonly due to amyloid angiopathy (in which the microbleeds have a primarily lobar distribution) or simple arteriolosclerosis (in which they are primarily in the deep grey matter) 44, 45 (TABLE 2) . Microbleeds reported in patients with MS might have been due to concomi tant vascular disease 46 as they were not observed when patients with vascular disease were excluded 47 ; therefore, the presence of microbleeds generally indicates SVD. Cortical siderosis is frequently seen with SWI in amyloid angiopathy 48 but not in MS. The presence of a WML central vein, identified as a hypointensity relative to the surrounding lesion on T2* or FLAIR* images and known as the central vein sign, is thought to be characteristic of MS lesions (FIG. 1) . Optimized T2* protocols can detect central veins in ~80% of MS lesions at 3T, but a smaller proportion of SVD lesions have central veins: a cutoff of 45% is highly pre dictive in distinguishing between the two conditions 49, 50 . However, visualizing all lesions is not practical in the clinical setting, and this cutoff might be less accurate in older patients with MS and vascular comorbidities 51 . Cortical lesions detected with 3T imaging proto cols (T1, T2 and DIR) are well described as features of MS 52, 53 (FIG. 1) . However, cortical microinfarcts (diameter <200 μm) occur in vascular disease and can be seen with DIR at 3T [54] [55] [56] but can be difficult to differentiate from MS cortical lesions in older patients with MS and/or patients with vascular risk factors.
Specific features of vascular disease depend on the underlying pathogenic process (TABLES 2,3). Cortical, subcortical and basal ganglia infarcts with restricted dif fusivity, as well as haemorrhages, can be present in many diseases that affect the vasculature (FIG. 3) . Additional features suggest certain diagnoses; for example, large diencephalic pseudotumoural lesions and cerebral venous thrombosis suggest neuroBehçet syndrome 15 ; leptomeningeal enhancement suggests many types of vasculitis; dural masses suggest granulomatosis with polyangiitis (formerly Wegener's granulomatosis) 57 ; increased T1 signal intensity in the pulvinar thalami and/or enlarged basilar artery diameters 58 suggest Fabry disease; and anterior temporal lobe pole and external capsular WMLs suggest cerebral autosomal dominant arteriopathy with subcortical infarcts and (FIG. 3) . The presence of multiple focal or long segments of vessel narrowing (FIG. 3) and concentric vessel wall contrast enhancement 60 helps to distinguish medium and large cerebral vasculi tis from MS 25, 57 . Finally, the central vein sign, assessed with SWI, was less common among patients with some autoimmune disorders that affect the small vessels (present in 15% of lesions) than among patients with MS ( present in 89% of lesions) 51 .
Spinal cord lesions.
Spinal cord MRI is included in the MS diagnostic criteria 2 and has a major role in the differ ential diagnosis, as incidental spinal cord lesions do not occur in normal ageing 61, 62 or in typical SVD 63 . Spinal cord infarcts rarely cause diagnostic difficulties clinically or with MRI 64 (TABLE 3) , although the risk factors for spi nal infarcts seem to differ from those for cerebral infarcts (patients with spinal cord infarction are younger, more often women, and less frequently have hypertension and cardiac disease than those with cerebral infarction) 65 .
Migraine
Migraine affects ~10-15% of the general popula tion 66 . WMLs that look similar to those associated with vascular disease on MRI, some of which have a peri ventricular location, are associated with migraine. Owing to the young age of presentation, these WMLs are a common cause of MS misdiagnosis 17 , particularly as their appearance on MRI can fulfil the radiological criteria for MS 8, 9 . Migraineassociated WMLs are typi cally small and nonconfluent in the deep white matter (sparing Ufibres), are more stable over time than MS lesions 66 , and occur adjacent to the body of the lateral ventricle less frequently than in MS 67 . The central vein sign might also be useful in differentiating migraine from MS: the median percentage of WMLs with the central vein sign was lower in migraine (22%) than in MS (84%), although there was some overlap (two of ten patients with migraine exhibited the central vein sign in 80% of WMLs) 68 . In addition, a simplified algorithm for determining the presence of the central vein sign (in three WMLs only) has proved accurate in differenti ating MS from migraine 69 . Another differentiating fea ture of migraine with aura is a higher prevalence of silent brain infarcts, particularly in the deep grey matter and cerebellum 70 , than seen in MS. Finally, cortical 10 and spinal cord lesions 71 might be helpful in diagnosing MS, as these lesions do not occur in migraine.
Neuromyelitis optica spectrum disorders
The clinical phenotype of NMOSD can overlap with that of relapsing-remitting MS, although NMOSD has a pre dilection for the optic nerve and spinal cord; involvement of the spinal cord is typically associated with longitudi nally extensive transverse myelitis (LETM). Nevertheless, a young female with NMOSD who initially presents with unilateral optic neuritis with poor recovery and a few WMLs is likely to be diagnosed with MS. The discov ery that serum antibodies against AQP4 water channels (which are present on astrocyte foot processes) are pres ent in 60-90% of patients with NMOSD has advanced the diagnostic criteria 72, 73 . The most recent criteria 74 use a single term (NMOSD) to describe all patients but divide patients into those who have antiAQP4 antibodies in addition to clinical disease (for whom imaging criteria only need to be satisfied in those without attacks that involve the optic nerve, spinal cord or brainstem) and those who do not have antiAQP4 antibodies (for whom diagnosis of NMOSD requires satisfaction of stricter imaging and clinical criteria). Further refinement of the criteria for antibodynegative NMOSD is likely, particu larly because ~20% of patients with this condition are serum positive for antiMOG antibodies [75] [76] [77] [78] [79] and not all such antiMOG antibodypositive patients fit into the current boundaries that define NMOSD 80 . In addition to the association with NMOSD, anti MOG antibodies are present in more than half of chil dren with ADEM 75, 78, 81, 82 and, in a study published in 2017, were detected in all 14 children with multiphasic Data are from a limited number of studies in which the MS imaging criteria were explored in other conditions. The findings support the view that these criteria should not be used in isolation. AQP4, aquaporin 4; DIS, dissemination in space; MOG, myelin-oligodendrocyte glycoprotein; MS, multiple sclerosis; NA, not available; NMOSD, neuromyelitis optica spectrum disorder; SLE, systemic lupus erythematosus. , other diagnoses should be considered according to the imaging features observed. Dissemination of lesions in time or the presence of oligoclonal bands is required to make the diagnosis in the absence of a better explanation. Even when the DIS criteria are met, other diagnoses can be considered. Having no brain or spinal cord lesions is rare and should be seen as a special case (dashed lines) in which complementary tests other than MRI are needed to support the diagnosis. ADEM, acute disseminated encephalopathy; NMOSD, neuromyelitis spectrum disorder; PML, progressive multifocal leukoencephalopathy. 83 . Although antiMOG antibodyassociated disease can be confused with MS (for example, in children) [84] [85] [86] , the general consen sus is that it represents a distinct disease 87 that can be monophasic or relapsing 14 .
Imaging features similar to MS
The old doctrine that most patients with NMOSD will have normal brain MRI scans has now been proved incorrect. Between 43% and 70% 88 of patients have brain lesions at onset, 13% of patients with NMOSD fulfil the Barkhof criteria for MS at disease onset 12 , and up to 42% might do so later in the disease 88 , although this proportion seems to be lower among antiAQP4 antibody positive cohorts 11, 13 (TABLE 1) . Nevertheless, periventricular WMLs 11 , corpus callosum lesions 88 , brainstem lesions and short spinal cord lesions (in 14% of initial transverse myelitis episodes 89 ) can occur in antiAQP4 antibodyassociated disease.
Antibodynegative NMOSD represents a hetero geneous group of disorders, and the overlap of clinical and imaging features in MS and NMOSD leads to consid erable inconsistencies in the diagnosis and management of patients 80 . Identification of specific MS and NMOSD imaging features will play an important diagnostic role in this group of patients.
Differentiation from MS
Brain and optic nerve lesions. Lesions that are considered typical of NMOSD, despite the fact that they are found in a minority of antiAQP4 antibodypositive patients 90 , are distinct from those seen in MS and are located in areas of high AQP4 expression in the brain. These areas include the periependymal areas that line the lateral, third and fourth ventricles, including diencephalic structures such as the thalamus, hypothalamus (FIG. 4) , posterior pitu itary, pineal gland and the brainstem, typically the area postrema 11, 90, 91 . Cloudlike, poorly marginated (FIG. 4) and socalled pencilthin ependymal enhancement can be seen in NMOSD, and distinguish this condition from MS [92] [93] [94] . AntiMOG antibodyassociated disease can pres ent with typical ADEM 85 or NMOSDlike 95 brain features. Adults and children with antiMOG antibodyassociated disease frequently have three or fewer brain lesions, which are characterized by a fluffy, cloudlike appearance and can involve the brainstem -often the pons and/or areas adjacent to the fourth ventricle -and, typically, the cerebellar peduncles 14, 87, 96 (FIG. 4) .
Callosal lesions in NMOSD are often located immedi ately adjacent to the lateral ventricles, following the ependymal lining (in contrast to those in MS, which are perpendicular to the ventricle wall), and can exhibit a characteristic 'arch bridge pattern' (REF. 97 ). Radial and spindleshaped WMLs, lesions that involve corticospinal tracts and, in rare cases, meningeal enhancement can occur in NMOSD 94, 98 but not in MS. A previous analysis of brain lesions showed that MS can be distinguished from antiAQP4 antibody positive and antiMOG antibodypositive NMOSD by use of defined criteria: "at least one lesion adjacent to the body of the lateral ventricle and in the inferior temporal lobe; or the presence of a subcortical Ufibre lesion; or a Dawson's finger type lesion" (REFS 11, 13) . Additionally, clinically silent lesion activity -defined as an annual increase in T2 lesion load -occurs in MS but does not usually occur outside of relapses in NMOSD 99 . Cortical lesions occur in MS 100 but are typically absent in NMOSD 101 , in keeping with the pathological findings 102 . Similarly, diffuse brain atrophy and diffuse cortical thin ning are observed in MS, whereas patients with NMOSD exhibit a lower degree of brain atrophy 103 , and cortical thinning in these patients is mild and limited to the motor, sensory and occipital cortices 101 . Whether deep grey mat ter abnormalities, such as volume loss and abnormalities in grey matter MTR and DTI, exist and help to differen tiate MS from NMOSD is less clear 99, 101, [104] [105] [106] [107] [108] . However, the thalamic atrophy seen in MS does not usually occur in NMOSD 91 , and changes in thalamic subregional frac tional anisotropy can distinguish NMOSD from MS with a sensitivity of 61% and a specificity of 92% 104 . In MS, the presence of widespread abnormalities in normalappearing tissues is commonly accepted. In NMOSD, such changes seem to be limited to tracks that connect to lesions, such as the optic nerve and spinal cord pathways 99 . Abnormal white matter brain changes visible with DTI in NMOSD seem to be limited to the splenium of the corpus callosum and the pos terior corona radiata -the latter was related to visual 25 . impairment 99 and to damage of the optic radiations 109 and corticospinal tracts 110 . Widespread white matter changes (beyond the optic radiations and the cortico spinal tracts) in NMOSD were reported in one study, but the patients had not been tested for antibodies, and lesion masking was not performed 111 . A study of the central vein sign in NMOSD and MS showed that this feature is less common in antiAQP4 antibodyassociated NMOSD (present in 32% of lesions) than in MS (80% of lesions) 112 . A cutoff of 54% was suggested as a way to reliably distinguish between the two disorders 112 . Astrocyte damage occurs in NMOSD, whereas astro cytic activation and gliosis typically occur in MS; there fore, myoinositol values measured with MRS -a marker of astrocytic damage -could be useful for distinguish ing between the conditions. Indeed, 3T MRS of spinal cord lesions revealed significantly lower myoinositol values in patients who were positive for antiAQP4 antibodies than in patients with MS and healthy con trols. The findings also indicated a trend towards higher levels in patients with MS 113 . Of interest, levels of Nacetylaspartate -a marker of neuronal integrityin lesions were significantly lower in patients with MS than in healthy controls, whereas only a nonsignificant trend towards a reduction was seen in patients who were positive for antiAQP4 antibodies 114 .
In contrast to MS, antiAQP4 antibodyassociated optic neuritis is often associated with a long optic nerve lesion that tends to be more posterior and can extend into the optic chiasm. Bilateral optic neuritis is char acteristic of antiMOG antibodyassociated disease and tends to involve the anterior visual pathway with associated optic nerve head swelling 115, 116 .
Spinal cord lesions. LETM, a contiguous spinal cord lesion spanning three or more vertebral segments, is a characteristic feature of antiAQP4 antibodyassociated transverse myelitis attacks. This feature is not specific and is often seen in monophasic idiopathic transverse myelitis, in antiMOG antibodyassociated disease (in which conus involvement is typical) 77, 95 and in other inflammatory and noninflammatory spinal cord dis orders, but it rarely occurs in MS 75, 117 . Also in contrast to MS, central, symmetrical T1hypointense spinal cord lesions that particularly involve central grey matter and often appear oedematous in the acute stages are typical of NMOSD 90 . 'Bright spotty' T2 cord lesions also occur more commonly in NMOSD than in MS 118, 119 . In the chronic stages of NMOSD, pronounced and extensive cord atrophy, with or without T2 hyperintensity 120 and occasionally with syrinxlike cavities 121 , can occur. LETM lesions that extend into the brainstem are more typical of NMOSD than of other causes of LETM 122 . The timing of spinal cord MRI in relation to the onset of symptoms is important for the identification of LETM. Early imaging might miss a long lesion that is developing, whereas late imaging might show a short ening or entirely resolved lesion 89, 120 . Given that the early scan performed for diagnostic reasons might not demonstrate the full extent of inflammation, further imaging might be indicated while a patient continues to deteriorate. Asymptomatic spinal cord lesions are less common in NMOSD than in MS, but gadolinium enhancement is present in the majority of, but not all, acute NMOSD transverse myelitis attacks 122, 123 . The pres ence of ringenhancing spinal cord lesions seems to be useful for distinguishing NMOSD from other causes of LETM but not for distinguishing NMOSD from MS 124 . Besides the differences in lesions, cervical cord atrophy and MTR abnormalities are absent or much less prom inent in patients with antiAQP4 antibodyassociated disease than in patients with MS 99, 103 .
Other MS imaging mimics
The differential diagnosis for MS includes a long list of conditions, including other CNS inflammatory diseases, infections, neoplasms and toxic, metabolic and heredi tary disorders, all of which can present with WMLs; these conditions have been reviewed in detail else where 3, 5, 6, 18, 57, 59, [125] [126] [127] [128] . Exclusion of all MS mimics is not trivial 3 , and a diagnosis of MS should be reevaluated in the presence of several features: an atypical clinical presentation; a positive family history; childhood or juvenile onset of symptoms; onset with a slow, isolated, progressive paraplegia, dystonia, epilepsy or psychiatric disorders; and peripheral nerve and extraCNS involve ment 5,59,129 together with specific MRI features and other Nature Reviews | Neurology paraclinical results (such as findings of serum and CSF analysis). Nevertheless, recognizing features that suggest alternative, often rare, diagnoses can be challenging, even for MS specialists. Whereas systematic identification of typical MS MRI features is incorporated into current MS diagnostic criteria, the approach to exclusion of alter native diagnoses is not standardized. In the following sections, we summarize key MRI features that suggest uncommon diseases associated with WMLs.
Brain lesions
Distribution. When considering brain MRI features, it is important to sequentially check each brain area. The most important of these areas are the white matter, white matter-grey matter junction, the grey matter and the brainstem.
Multiple WMLs that have poorly defined margins, are all the same age and are not adjacent to the ventricles indicate monophasic disorders such as ADEM 130 . This pattern is distinct from MS, for which lesions must be of different ages (disseminated in time) and chronic and are typically adjacent to the ventricles.
Bilateral, confluent and symmetrical WMLs that spare the Ufibres (which MS lesions do not) are char acteristic of the inherited leukodystrophies (FIG. 5) . The WML distribution patterns and associated features can narrow the diagnostic options to identify specific leukodystrophies 59, 128 . The observed pattern of corpus callosum involve ment can suggest specific diagnoses. Central 'snow ball' lesions are typical of Susac syndrome 131 (FIG. 5) .
Extensive, symmetrical, poorly defined, bridgelike 
No lesions
Migraine, dilated Virchow-Robin spaces and SVD
Magnetic resonance angiography, nonconventional or quantitative imaging

Imaging characteristics
Multiple arterial stenosis and post-stenotic dilatations and/or vessel wall contrast enhancement 
Reduced myoinositol in lesions Anti-AQP4 antibody-associated transverse myelitis
Not all possible differential diagnoses of multiple sclerosis are included, only those that have been reported to mimic multiple sclerosis. ADEM, acute disseminated encephalopathy; AQP4, aquaporin 4; CADASIL, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; CLIPPERS, chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids; COL4A1, collagen-α1(IV) chain mutations; DARS, aspartate-tRNA ligase, cytoplasmic; FLAIR, fluid-attenuated inversion recovery; GPA, granulomatosis with polyangiitis; HTLV1, human T cell lymphotropic virus type 1; ITM, idiopathic transverse myelitis; MA2, paraneoplastic antigen Ma2; MOG, myelin-oligodendrocyte glycoprotein; NMOSD, neuromyelitis optica spectrum disorder; PRES, posterior reversible encephalopathy syndrome; SLE, systemic lupus erythematosus; SVD, small vessel disease.
lesions indicate CNS lymphoma and glioblastoma 132 . Predominant involvement of the central layers of the corpus callosum suggests severe malnutrition and alcoholism 133 . The white matter-cortex junction should be care fully checked. Juxtacortical lesions (in Ufibres that abut the cortical ribbon) are typical of MS, but lesions that spread through the white matter-grey matter junction into the superficial layers of the cortex are uncom mon in MS. Such lesions are seen in ADEM 130 , infarcts (when lesions are typically wedgeshaped and point to the white matter; FIG. 3) , GABA A autoantibody disease (in which lesions usually have a fluffy appearance) 134 , progressive multifocal leukoencephalopathy (PML; in which lesions have a predilection for the frontal lobes and have sharp grey matter borders and illdefined white matter borders; FIG. 5) 135-140 and mitochondrial encephalomyopathy, lactic acidosis strokelike epi sodes syndrome (MELAS; in which lesions are not confined to vascular territories) 141 . PML lesions can be unifocal (particularly in the presymptomatic phase) or multi focal, and tend to be confluent at late stages of the disease. Lesions become increasingly hypointense over time on T1weighted images (FIG. 5) , and T2weighted imaging can reveal a microcyst or granular pattern 142 . Cortical lesions can be seen in some systemic auto immune disorders, such as systemic lupus ery thematosus 143 , and some, but not all 144 , inherited leuko dystrophies, such as adultonset leukodystrophy 145 . However, the value of detecting cortical lesions with DIR in differentiating MS from other acquired and inherited disorders that affect the white matter is unknown.
Symmetrically distributed deep grey matter (thala mus and basal ganglia) lesions suggest ADEM 130, 146 , inherited metabolic and mitochondrial disorders 141 , extrapontine myelinolysis 147 , infection and lymphoma 148 . MRI signal abnormalities in specific thalamic or hypo thalamic areas can also indicate alternative diagnoses; for example, abnormalities in the lateral geniculate body indicate Xlinked adrenoleukodystrophy 149 , abnormal ities in the mammillary bodies indicate thiamine defi ciency 150 , and abnormalities in the hypothalamus and pituitary gland indicate sarcoidosis 151 .
When diffuse, illdefined brainstem involvement is pre dominant, CNS infections (such as listeriosis (FIG. 5) and Whipple disease), vasculitis and neoplasms should be con sidered 152 . A bias towards involvement of specific brain stem regions can also suggest specific diagnoses. In central pontine myelinolysis, which is associated with nutritional or electrolyte abnormalities, the lesions can (as in MS) be T2 bright, hypointense on T1weighted sequences, and can occasionally cause enhancement in the border regions. The restricted location of these lesions, combined with sparing of the ventrolateral pons, tegmentum and corti cospinal tracts, gives a characteristic 'tridentshaped' or 'batwinged' appearance 147 . Midbrain changes, such as the hummingbird sign, have also been reported in globoid cell leukodystrophy, and periaqueductal grey matter changes have been described in Leigh disease 59, 128 . Brainstem pial FLAIR hyperintensity and tadpole atrophy (atrophy of the medulla and spinal cord with relative sparing of the pons) are seen in type II (lateonset) Alexander disease 153 . Finally, cerebellar dentate nucleus hyperintensities are typical of cerebrotendinous xanthomatosis 154 
(FIG. 5).
Features and enhancement patterns. Tumefactive lesions are uncommon in MS. An open ring enhance ment that points towards the grey matter is seen more frequently in demyelination than with tumours, but this feature is not specific 155 . Lesion expansion over time and persistent oedema should alert physicians to other pos sible diagnoses, such as neoplasms. Cerebral lymphoma characteristically presents with lesions that cause vivid, homogeneous enhancement, which might be pres ent simultaneously in all lesions, can persist and can be associ ated with restricted diffusivity. Furthermore, areas that are enhanced on MRI appear hypodense on unenhanced CT images for 93% of demyelinating lesions but for only 4% of tumours, suggesting that comparing results of the two imaging tests is useful in distinguish ing between diagnoses 156 . CT of the brain can also reveal calcifications that are characteristic of specific infections (such as toxoplasmosis) and metabolic disorders 3, 141 . Punctate and curvilinear enhancing lesions in the pons are typical of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to Nature Reviews | Neurology a b steroids (CLIPPERS) 157 . Punctate enhancing lesions vis ible on T2weighted or T1weighted contrast enhanced images have also been observed in patients with early natalizumabassociated PML 137 . Linear contrast enhancement, particularly that which follows specific tracts, can feature in some inherited leukodystrophies, such as Xlinked adrenoleukodystrophy 59 . Cavitations are not common in MS but can be observed in inherited leukodystrophies (such as vanish ing white matter disease, in which cavitations typically have an anterior location 149 ) and in mitochondrial dis orders, in which they are in the cerebral and cerebellar white matter 59, 141 . Spectroscopy can help to differentiate MS from mitochondrial diseases: a characteristic lactate peak is present in mitochondrial disease but not in MS 141 .
Leptomeningeal enhancement seen with MRI is a red flag that indicates CNS infection (for example, Lyme disease, Brucellosis), sarcoidosis, vasculitis or Susac syn drome as possible alternative diagnoses 158, 159 . Cranial nerve enhancement (FIG. 5) -except for the optic nerve and initial portion of the trigeminal nerves 160 -and spinal root enhancement are not seen in MS but do occur in CNS infection and sarcoidosis 161 . Postcontrast T2weighted FLAIR MRI can detect small foci of lepto meningeal inflammation in MS, which might prove to be useful in distinguishing MS from noninflammatory white matter conditions 162 .
Spinal cord lesions
An LETM with gadolinium enhancement and cord swelling due to oedema is another important red flag that indicates an alternative diagnosis such as NMOSD, ADEM, sarcoidosis (FIG. 5) or infection 64, 151 . Spinal cord sarcoidosis predominantly affects the thoracic seg ments; central canal enhancement alone or in combi nation with dorsal subpial enhancement, resembling a trident (FIG. 5) , has been reported 163 . Spondylosis might confound the diagnosis of MS. Transverse pancakelike gadolinium enhancement that is associated with and is just caudal to the site of maximal stenosis, and is at the rostrocaudal midpoint of a spinal cord spindleshaped T2 hyperintensity, suggests that spondylosis is the cause of myelopathy 164 . Spinal cord lesion enlargement, nod ules, haemorrhage and cavitations are atypical in MS but can feature in neoplasms, sarcoidosis and infections 165 . Vitamin B 12 deficiency and copperdeficiency associated myelopathy cause demyelination of long fibre tracts (spinal dorsal and lateral columns and brain pyramidal and spinocerebellar tracts). These conditions result in T2 hyperintensities that are usually symmetrical in axial sections, so goodquality axial imaging is needed for an accurate diagnosis [166] [167] [168] .
Single lesion or absence of lesions
In a patient with a clinical course that indicates primary progressive MS, a single demyelinating lesion in the spi nal cord, brainstem or cerebral white matter could indi cate progressive solitary sclerosis 169 . In the presence of single lesions, particularly those that increase in size over time, brain tumours and infection should be considered and excluded 3 . Similarly, a normal brain and spinal cord MRI is rare in patients with MS, so if a patient presents with clinical symptoms of MS but no detectable lesions, alternative diagnoses should be considered. Such diagno ses include hereditary spastic paraparesis and metabolic disease, such as vitamin B 12 or copper deficiency.
Summary of imaging differentiators
In summary, specific MRI features can help to make alternative diagnoses when MS is suspected T2-FLAIR imaging reveals hyperintense lesions that typically involve the grey matter-white matter transition, with sharp lesional borders in the grey matter and ill-defined borders in the white matter. Such lesions appear as hyperintensities (arrow) with axial FLAIR imaging (top) and as hypointensities (arrow) with T1-weighted imaging (middle). Crescent-shaped lesions involving the middle cerebellar peduncles and adjacent pontine white matter (box) also occur in PML, visible with axial FLAIR imaging (bottom). f | Imaging features of sarcoidosis. Longitudinally extensive spinal cord lesions (box) can be seen in a sagittal T2-weighted cervicothoracic spinal cord scan (top). Central canal enhancement alone or in combination with dorsal subpial enhancement -known as the trident sign (arrow) owing to its resemblance to a trident -is also a feature of spinal cord sarcoidosis, illustrated in a thoracic cord axial post-contrast T1-weighted image (bottom).
and strictly symmetrical WMLs suggest a diagnosis other than MS. These features should be systematically excluded, and we suggest the simple mnemonic 'iMIM ICS' to represent the imaging red flags. The mnemonic stands for: patterns of meningeal (M) enhancement; indistinct (I) border or increasing (I) lesion size; the presence of macrobleeds (M) or microbleeds (M); the presence of cortical or lacunar infarcts (I); the pres ence of cavities (C), complete (C) ring enhancement or calcifications (C); and symmetrical (S) lesions, lesions that spare (S) the Ufibres, siderosis, and spinal (S) cord extensive lesions (TABLE 4) . However, the clinical picture might be more useful for refuting the diagnosis of MS than is the presence of MRI red flags 170 .
Conclusions
In this Review, we suggest a diagnostic algorithm (FIG. 2) that incorporates the current MS diagnostic criteria, fea tures that have been identified as useful in differenti ating MS from NMOSD, and imaging features that suggest other alternative diagnoses. Although this algorithm is intended to promote homogenization of a differential diagnostic approach, its ability to improve the specificity of MRI still needs to be tested. Several challenges remain. First, MS commonly coexists with disorders (such as migraine and cerebro vascular disease) that can have a similar appearance on MRI, and its interaction with and separation from these disorders warrants further studies. Such studies can be done only with cohorts of MS patients for whom comorbidity data are clearly documented, and cohorts of appropriate controls. Second, with the exception of CIS, use of the current MS diagnostic criteria has not been studied across other MS mimics. Direct compari sons between disorders was a useful approach in deter mining imaging features that differentiate between MS, NMOSD with brain involvement 11 and migraine 67 , but similar comparative studies are lacking for many other neurological diseases that mimic MS. Third, differ entiating MS from mimics relies on good clinical and neuroradiological expertise, along with the ability to per form highquality and stateoftheart MRI protocols; such expertise is often not available outside specialized research centres. The use of pulse sequences, such as SWI and DIR, which are usually not done in routine clinical scans, enabled identification of the central vein sign and cortical lesions, promising MRI measures that could have a role in the diagnostic criteria of MS 10, 51 and might help to identify features of other disorders, such as microbleeds in SVD. Finally, owing to the rarity of some MS mimics, the evidence for differentiating features of these conditions comes from case reports and series, so the reliability of these discriminators is unknown. Direct comparative studies that include larger numbers of patients would clarify their accuracy.
Despite these challenges, most typical MS patients are diagnosed accurately and speedily, particularly in areas of the world in which MS is common. Nevertheless, many people with unconventional clinical features might still have MS. Incorporating the differentiating imaging fea tures described in this Review into the diagnostic process should improve diagnostic accuracy. Importantly, the neurologist should also maintain an open mind when following up patients who have been diagnosed with MS but who have atypical clinical or imaging features. • Siderosis 2D axial T2*-weighted gradient echo or FLAIR
• Spinal cord extensive lesions Sagittal dual echo (proton-density and T2-weighted) and/or fast spin echo, contrast-enhanced T1-weighted spin echo and axial 2D and/or 3D T2 and contrast-enhanced T1 weighted fast spin echo DWI, diffusion-weighted imaging; FLAIR, fluid-attenuated inversion recovery.
